l carnitine blood flow Therapeutic potential of L-carnitine in coronary artery disease: a systematic review | Inflammopharmacology Carnitine in Mitochondrial Fatty Acid

Harmsen, H

I've also recently had a head and spine MRI and am awaiting the results of those

The 2015 review in BioMed Research International summarized the evidence across multiple tissue types

Bacteria can adopt several biochemical strategies to evade antimicrobial effects

Starting at the lower end (200-250mcg) allows tolerance assessment and side effect minimization before increasing to therapeutic doses, while taking doses higher than prescribed does not necessarily lead to additional benefit and may increase the risk of side effects due to physiologic feedback mechanisms

C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: Relevance to disease and ageing